new_0222_0301|OLMA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0301|OLMA|Long Name|1|1|Olema Pharmaceuticals inc Total Current Assets (Quarterly) (USD)|Olema Pharmaceuticals inc Cash and Short Term Investments (Quarterly) (USD)|Olema Pharmaceuticals inc Inventories (Quarterly) (USD)|Olema Pharmaceuticals inc Net PP&E (Quarterly) (USD)|Olema Pharmaceuticals inc Goodwill and Intangibles (Quarterly) (USD)|Olema Pharmaceuticals inc Total Liabilities (Quarterly) (USD)|Olema Pharmaceuticals inc Total Current Liabilities (Quarterly) (USD)|Olema Pharmaceuticals inc Total Long Term Liabilities (Quarterly) (USD)|Olema Pharmaceuticals inc Total Deposits (Quarterly) (USD)|Olema Pharmaceuticals inc Book Value (Quarterly) (USD)|Olema Pharmaceuticals inc Retained Earnings (Quarterly) (USD)|Olema Pharmaceuticals inc Treasury Stock (Quarterly) (USD)|Olema Pharmaceuticals inc EV to Revenues|Olema Pharmaceuticals inc EV to Earnings|Olema Pharmaceuticals inc EV to Free Cash Flow|Olema Pharmaceuticals inc EV to Assets (Quarterly)|Olema Pharmaceuticals inc PS Ratio|Olema Pharmaceuticals inc PE Ratio|Olema Pharmaceuticals inc Price to Book Value|Olema Pharmaceuticals inc PEG Ratio|Olema Pharmaceuticals inc Debt to Equity Ratio|Olema Pharmaceuticals inc Dividend Yield|Olema Pharmaceuticals inc Shareholder Yield (TTM)|Olema Pharmaceuticals inc Percent of Shares Outstanding Short|Olema Pharmaceuticals inc Total Receivables (Quarterly) (USD)|Olema Pharmaceuticals inc Total Payables (Quarterly) (USD)|Olema Pharmaceuticals inc Total Capital Stock (Quarterly) (USD)|Olema Pharmaceuticals inc Return on Invested Capital|Olema Pharmaceuticals inc Quality Ratio Score|Olema Pharmaceuticals inc Momentum Score|Olema Pharmaceuticals inc Beta (1Y)|Olema Pharmaceuticals inc Sustainable Growth Rate (TTM)|Olema Pharmaceuticals inc Institutional Investor Ownership Percentage|Olema Pharmaceuticals inc Average Diluted Shares Outstanding (Quarterly)|Olema Pharmaceuticals inc Total Employees (Annual)|Olema Pharmaceuticals inc EPS Diluted (Quarterly) (USD)|Olema Pharmaceuticals inc Shares Outstanding|Olema Pharmaceuticals inc Repurchase of Capital Stock (Quarterly) (USD)|Olema Pharmaceuticals inc Ordinary Shares Number (Quarterly)|Olema Pharmaceuticals inc Payout Ratio|Olema Pharmaceuticals inc Quick Ratio (Quarterly)|Olema Pharmaceuticals inc Normalized Diluted EPS (Quarterly) (USD)|Olema Pharmaceuticals inc Stock Buybacks (Quarterly) (USD)|Olema Pharmaceuticals inc Effective Tax Rate (TTM)|Olema Pharmaceuticals inc Return on Equity|Olema Pharmaceuticals inc Net Income (TTM) (USD)|Olema Pharmaceuticals inc Revenue (TTM) (USD)|Olema Pharmaceuticals inc Dividend Per Share (Quarterly) (USD)|Olema Pharmaceuticals inc Revenue (Quarterly) (USD)|Olema Pharmaceuticals inc Gross Profit (Quarterly) (USD)|Olema Pharmaceuticals inc SG&A Expense (Quarterly) (USD)|Olema Pharmaceuticals inc Pre-Tax Income (Quarterly) (USD)|Olema Pharmaceuticals inc Net Income (Quarterly) (USD)|Olema Pharmaceuticals inc Net Interest Income (Quarterly) (USD)|Olema Pharmaceuticals inc Price (USD)|Olema Pharmaceuticals inc Total Return Price (USD)|Olema Pharmaceuticals inc Enterprise Value (USD)|Olema Pharmaceuticals inc 30-Day Average Daily Volume|Olema Pharmaceuticals inc 1 Year Price Returns (Daily)
new_0222_0301|OLMA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0301|OLMA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily
new_0222_0301|OLMA||5|5|127.8|127.8|0|127.8|0|127.8|127.8|127.8|0|127.8|127.8|0|0|0|1.44912280702|0|0|0|1.45222929936|0|0|1.45367412141|0|15.25|0|127.8|127.8|0|0|31|31|0|0|91.2857142857|45|91.2857142857|32.1818181818|91.25|127.8|0|0|91.2857142857|0|0|0|91.25|0|0|0|0|91.2857142857|91.2857142857|91.2857142857|91.2857142857|1.45222929936|1.45222929936|1.45367412141|1.44014084507|1.47540983607
new_0222_0301|OLMA||6|6|5|5|0|5|0|5|5|5|0|5|5|0|0|0|285|0|0|0|314|0|0|313|0|28|0|5|5|0|0|1|2|0|0|7|1|7|11|4|5|0|0|7|0|0|0|4|0|0|0|0|7|7|7|7|314|314|313|284|61
new_0222_0301|OLMA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0301|OLMA|201912|201912|201912|0.103|0.068||0.026||10.726|1.378|9.348||-10.594|-10.762|||||||||||||||0.935|0|||||||14.0986||-0.0721|||37.5197|||-0.0721|||||||||0.107|-1.017|-1.017|0|||||
new_0222_0301|OLMA|202003|202003|202003||||||||||||||||||||||||||||||||||14.0986||-0.1201||||||-0.1201|||||||||0.248|-1.693|-1.693|-0.65|||||
new_0222_0301|OLMA|202006|202006|202006||||||||||||||||||||||||||||||||||14.0986||-0.174||||||-0.174|||||||||0.539|-2.453|-2.453|0.033|||||
new_0222_0301|OLMA|202009|202009|202009|129.087|127.824||0.024||5.273|5.273|0||125.41|-22.963|||||||||||||||0.097|0.003|||||||37.5197||-0.2589||-2.289|39.3082|||-0.2091||||-13.007|||||3.195|-7.844|-7.844|0.023|||||
new_0222_0301|OLMA|202011|202009|202009|||||||||||||||||||16.3357|||0||1.0918|||||||||25.7919||22||40.1697||||||||||||||||||51|51|1920.8307||
new_0222_0301|OLMA|202012|202012|202012|342.137|338.549||0.075||4.585|4.585|0||338.137|-33.094||||-77.8732||||5.5893|||0||1.8086||1.361|0.003|||||||39.3082|37|-0.5|39.3082|0|39.3082|||-0.5||||-22.121|||||3.842|-10.131|-10.131|0.001|48.08|48.08|1551.3893||
new_0222_0301|OLMA|202101|202012|202012|||||||||||||||-66.7646||||4.9348|||0||1.1891|||||||||||||||||||||||||||||||42.45|42.45|1330.0841|87569.1333|
new_0222_0301|OLMA|202102|202012|202012|||||||||||||||-61.7726||||4.6407|||0||1.1786|||||||||||||||||||||||||||||||39.92|39.92|1230.6343|92300.3333|
new_0222_0301|OLMA|202103|202103|202103|330.265|326.968||0.526||5.277|5.277|0||326.024|-48.433||||-34.3521||||4.0881|||0||2.1434||0.49|0.003|||||||39.3258||-0.39|40.1697||40.1697|||-0.39||||-35.767|||||4.758|-15.339|-15.339|0.111|33.18|33.18|1005.8626|226091.9|
new_0222_0301|OLMA|202104|202103|202103|||||||||||||||-27.3144||||3.4561|||0||3.3182|||||||||||||40.1697||||||||||||||||||28.05|28.05|799.7921|216664.4|
new_0222_0301|OLMA|202105|202103|202103|||||||||||||||-27.1909||||3.445|||0||4.7999|||||||||||||40.1697||||||||||||||||||27.96|27.96|796.1768|174831.6|
new_0222_0301|OLMA|202106|202106|202106|320.854|318.144||0.866||8.146|8.146|0||314.084|-64.839||||-21.107||||3.5235|||0||5.7068||0.452|0.003|||||||39.4153||-0.42|39.5526||39.5526|||-0.42||||-49.72|||||4.612|-16.406|-16.406|0.117|27.98|27.98|788.5377|280866.2667|
new_0222_0301|OLMA|202107|202106|202106|||||||||||||||-16.3428||||2.9568|||0||6.0937|||||||||||||||||||||||||||||||23.48|23.48|610.551|244184.3333|
new_0222_0301|OLMA|202108|202106|202106|||||||||||||||-23.1651||||3.7683|||0||5.2178|||||||||||||39.5578||||||||||||||||||29.92|29.92|865.4254|265683.1|
new_0222_0301|OLMA|202109|202109|202109|308.28|305.954||0.975||8.901|8.901|0||300.894|-82.552||||-18.7418||||3.6346|||0||6.0811||0.373|0.003|||||||39.6077||-0.45|39.6813|0|39.6813|||-0.45||||-59.589|||||5.239|-17.713|-17.713|0.105|27.56|27.56|787.6626|364130.2667|
new_0222_0301|OLMA|202110|202109|202109|||||||||||||||-18.2131||||3.5607|||0||6.7981|||||||||||||||||||||||||||||||27|27|765.4411|338222|
new_0222_0301|OLMA|202111|202109|202109|||||||||||||||-1.1079||||1.1716|||0||10.0905|||||||1.7402||||||40.2876||||||||||||||||||8.75|8.75|46.5625|868674|-82.8431
new_0222_0301|OLMA|202112|202112|202112|||||||||||||||-1.6927||||1.2532|||0||9.5204||||||1|1.9879||||||||||||||||||||||||9.36|9.36|71.1379|1317534.5667|-80.5324
new_0222_0301|OLMA|202201|202112|202112|||||||||||||||1.1161||||0.8609|||0||6.4886||||||1|2.4005||||||||||||||||||||||||6.43|6.43|-46.9047|451306.5667|-84.8528
new_0222_0301|OLMA|202202|202112|202112|||||||||||||||2.6882||||0.6078|||0|||||||||||||||||||||||||||||||||4.54|4.54|-112.9764|461933.2333|-90.6042